Imatinib mesylate: a novel immune suppressive agent? [PDF]
, 2004 Richard T. Maziarz
openalex +1 more source
Combined administration of imatinib mesylate and ionizing radiation leads to increased radiosensitivity in the human glioblastoma cell line RuSi RS1 [PDF]
, 2004 Matthias Holdhoff +9 more
openalex +1 more source
Imatinib-mesylate for all patients with hypereosinophilic syndrome? [PDF]
, 2004 Pellegrino Musto
openalex +1 more source
Peritoneal tuberculosis after imatinib therapy. [PDF]
, 2009 Kovacsovics, T. +3 more
core +1 more source
The effect of radiolabeled nanostructured lipid carrier systems containing imatinib mesylate on NIH-3T3 and CRL-1739 cells. [PDF]
Drug Deliv, 2020 Gundogdu EA +6 more
europepmc +1 more source
Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia. [PDF]
Front Pharmacol, 2020 Chen Y +6 more
europepmc +1 more source
Imatinib as a novel therapeutic approach for fibrotic disorders [PDF]
, 2017 Distler, J. H. W., Distler, O.
core
Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro. [PDF]
Oncol Lett, 2019 Kroschwald LM +7 more
europepmc +1 more source